France

[Funding alert] Paris-based Biotech Firm Amatera Secures €1.5 million in Pre-seed Funding

Oct 26, 2023 | By Startup Rise EU

Paris-based Biotech Firm Amatera secures €1.5 million in pre-seed funding round was led by PINC (Paulig’s venture arm) and included participation from Exceptional Ventures, Mudcake, Joyance Partners, Agfunder and some angel investors including Nicolas Morin-Forest from Gourmey.
OMAR DEKKICHE - CEO (Left) , LUCIE KRIEGSHAUSER - CTO (Right)

Paris-based Biotech Firm Amatera secures €1.5 million in pre-seed funding round was led by PINC (Paulig’s venture arm) and included participation from Exceptional Ventures, Mudcake, Joyance Partners, Agfunder and some angel investors including Nicolas Morin-Forest from Gourmey.

Read also - UK-based Globacap Secures $21Million Series B Round Funding

For usage with perennial crops, Amatera developed a non-GMO breeding platform that speeds up plant selection and cross-breeding while advancing plant cell culture.

First, due to diseases and climate change, methods are being utilized to maintain coffee plants, assisting them in adapting to the environment they are now required to thrive in.

Read also -  Amsterdam-based Climate Tech Startup Overstory Secures $14M Series A Round Funding

Lucie Kriegshauser, CTO of Amatera said, “Our approach is based on accelerating the plant’s natural evolution at the cellular level, which is an alternative non-GMO route to genome editing. The technology as such is not new but applying it to perennial crops such as coffee is, since they are more complicated and require several breakthroughs in cell biology,"

RECOMMENDED FOR YOU

recomd
Funding
[Funding alert] London-based Lilli Secures £8.2 Million in Series A Round Funding
Startup Rise EU
Feb 8, 2024
recomd
Netherland
Amsterdam-based AI-powered Product Discovery Platform NEXT Acquires Reveall
Startup Rise EU
Nov 8, 2023
recomd
Funding
[Funding alert] London-based AudioStack Secures €2.9 Million in Pre- Series A Round Funding
Startup Rise EU
Feb 6, 2024

Kriegshauser who founded the firm with Omar Dekkiche said,"This is also why gene editing techniques are struggling. Our technology is a real game-changer and opens up the avenue to applying it on several other crops, such as cacao, bananas and grapes or even pharmaceutical plants,".

Marika King, Head of PINC said, “We love the disruptive potential and versatility of the platform since it can be used on several crops. Coffee has traditionally not received as much research and innovation as many other crops globally, and as coffee is one of Paulig’s core products, we are of course happy that Amatera’s first solution involves coffee,".

About Amatera

Amatera's goal is to create the coffee types of the future by utilizing cutting-edge biotechnology processes. While we consume a trillion cups of coffee annually—a figure that is projected to triple by 2050—rising temperatures will, in the interim, cause a fifty percent decrease in the area appropriate for coffee cultivation.

To meet this enormous demand, it has to be done to create coffee varietals that are more climate resilient and sustainable.

Read also - Accenture Acquires ON Service GROUP to Help Insurers in Germany Improve Operational Resiliency

Recommended Stories for You

story
Recent Articles

[Funding alert] Copenhagen-based Biotech Startup Octarine Bio Secures €4.35 Million in Funding

Startup Rise EU Nov 8, 2023

story
Funding

[Funding alert] Stuttgart-based Metergrid secures €2.7 million Seed Funding

Startup Rise EU Sep 27, 2023

story
Funding

[Funding alert] London-based Pactio Secures $14 million in Series A Round Funding

Startup Rise EU Apr 11, 2024

story
Funding

[Funding alert] Amsterdam-based Biotech Company VectorY Therapeutics Raises €129M in a Series A Round Funding

Startup Rise EU Nov 18, 2023

story
Funding

[Funding alert] London-based mobility insurtech Startup Laka Secures €7.6 million in Funding

Startup Rise EU Oct 24, 2023

story
Funding

[Funding alert] London-based Monument Secures over $50M in Series B Round Funding

Startup Rise EU Nov 10, 2023